Please enable JS

50 State Network Advocate Talking Points: Non-Preferred and Specialty Tier Drugs

1. As patients, our core concerns are to safeguard safety and the physician-patient relationship.

2. We believe only physicians should decide if a non-preferred or specialty tier drug is right for their patients.

3. Patients should pay the same for non-preferred drugs as they do for preferred drugs when it is the best or only option.

4. Cost-sharing of specialty drugs should be capped at $100 per month for one prescription, or a total of $200 per month for multiple prescriptions.

5. Transparency is key; costs should be understandable and affordable.